Identification and Isolation of Slow-Dividing Cells in Human Glioblastoma Using Carboxy Fluorescein Succinimidyl Ester (CFSE)

Tumor heterogeneity represents a fundamental feature supporting tumor robustness and presents a central obstacle to the development of therapeutic strategies(1). To overcome the issue of tumor heterogeneity, it is essential to develop assays and tools enabling phenotypic, (epi)genetic and functional...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Deleyrolle, Loic P., Rohaus, Mark R., Fortin, Jeff M., Reynolds, Brent A., Azari, Hassan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MyJove Corporation 2012
Gaiak:
Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466660/
https://ncbi.nlm.nih.gov/pubmed/22565048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/3918
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak